Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings

Sign up to stay up to date with the stocks you care about

Add GSK PLC to Feed

GSK PLC

Latest news & discussion for GSK PLC:

1

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | about 2 months ago | 0 comments

2

1

GSK PLC B7-H3 ADC US FDA Breakthrough Therapy Designation

Posted by AssetRoom | about 2 months ago | 0 comments

3

1

GSK PLC Statement: Zantac (ranitidine) litigation

Posted by AssetRoom | about 2 months ago | 0 comments

4

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | about 2 months ago | 0 comments

5

1

GSK PLC Statement: Zantac (ranitidine) litigation

Posted by AssetRoom | 2 months ago | 0 comments

6

1

GSK PLC FDA Expands Jemperli Approval

Posted by AssetRoom | 2 months ago | 0 comments

7

1

GSK PLC Total Voting Rights

Posted by AssetRoom | 2 months ago | 0 comments

8

1

GSK PLC 2nd Quarter Results

Posted by AssetRoom | 2 months ago | 0 comments

9

1

GSK PLC Statement: Zantac (ranitidine) litigation

Posted by AssetRoom | 2 months ago | 0 comments

10

1

GSK PLC CHMP positive opinion on Arexvy for 50-59 at risk

Posted by AssetRoom | 2 months ago | 0 comments

11

1

GSK PLC Blenrep EMA Filing Acceptance

Posted by AssetRoom | 3 months ago | 0 comments

12

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 3 months ago | 0 comments

13

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 3 months ago | 0 comments

14

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 3 months ago | 0 comments

15

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 3 months ago | 0 comments

16

1

GSK PLC GSK and CureVac collaboration restructured

Posted by AssetRoom | 3 months ago | 0 comments

17

1

GSK PLC Total Voting Rights

Posted by AssetRoom | 3 months ago | 0 comments

18

1

GSK PLC Statement: Zantac (ranitidine) litigation

Posted by AssetRoom | 3 months ago | 0 comments

19

1

GSK PLC Omjjara approved in Japan for myelofibrosis

Posted by AssetRoom | 3 months ago | 0 comments

20

1

GSK PLC EMA validates Jemperli marketing authorisation

Posted by AssetRoom | 3 months ago | 0 comments

21

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 4 months ago | 0 comments

22

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 4 months ago | 0 comments

23

1

GSK PLC Statement: Zantac (ranitidine) litigation

Posted by AssetRoom | 4 months ago | 0 comments

24

1

GSK PLC Statement: Zantac (ranitidine) litigation

Posted by AssetRoom | 4 months ago | 0 comments

25

1

GSK PLC FDA approves Arexvy for adults 50-59 at risk

Posted by AssetRoom | 4 months ago | 0 comments